Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11818508rdf:typepubmed:Citationlld:pubmed
pubmed-article:11818508lifeskim:mentionsumls-concept:C0206131lld:lifeskim
pubmed-article:11818508lifeskim:mentionsumls-concept:C0021641lld:lifeskim
pubmed-article:11818508lifeskim:mentionsumls-concept:C0178719lld:lifeskim
pubmed-article:11818508lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:11818508lifeskim:mentionsumls-concept:C0595934lld:lifeskim
pubmed-article:11818508lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:11818508lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:11818508pubmed:issue2lld:pubmed
pubmed-article:11818508pubmed:dateCreated2002-1-30lld:pubmed
pubmed-article:11818508pubmed:abstractTextWe have examined the requirement for intracellular calcium (Ca(2+)) in insulin signal transduction in 3T3-L1 adipocytes. Using the Ca(2+) chelator 1,2- bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid, sodium (BAPTA-AM), we find both augmentation and inhibition of insulin signaling phenomena. Pretreatment of cells with 50 microM BAPTA-AM did not affect tyrosine phosphorylation of insulin receptor substrate (IRS)1/2 or insulin receptor (IR)beta. The decreased mobility of IRS1 normally observed after chronic stimulation with insulin, due to serine phosphorylation, was completely eliminated by Ca(2+) chelation. Correlating with decreased insulin-induced serine phosphorylation of IRS1, phosphotyrosine-mediated protein-protein interactions involving p85, IRS1, IRbeta, and phosphotyrosine-specific antibody were greatly enhanced by pretreatment of cells with BAPTA-AM. As a result, insulin-mediated, phosphotyrosine-associated PI3K activity was also enhanced. BAPTA-AM pretreatment inhibited other insulin-induced phosphorylation events including phosphorylation of Akt, MAPK (ERK1 and 2) and p70 S6K. Phosphorylation of Akt on threonine-308 was more sensitive to Ca(2+) depletion than phosphorylation of Akt on serine-473 at the same insulin dose (10 nM). In vitro 3'-phosphatidylinositol-dependent kinase 1 activity was unaffected by BAPTA-AM. Insulin-stimulated insulin-responsive glucose transporter isoform translocation and glucose uptake were both inhibited by calcium depletion. In summary, these data demonstrate a positive role for intracellular Ca(2+) in distal insulin signaling events, including initiation/maintenance of Akt phosphorylation, insulin-responsive glucose transporter isoform translocation, and glucose transport. A negative role for Ca(2+) is also indicated in proximal insulin signaling steps, in that, depletion of intracellular Ca(2+) blocks IRS1 serine/threonine phosphorylation and enhances insulin-stimulated protein-protein interaction and PI3K activity.lld:pubmed
pubmed-article:11818508pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818508pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818508pubmed:languageenglld:pubmed
pubmed-article:11818508pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818508pubmed:citationSubsetIMlld:pubmed
pubmed-article:11818508pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818508pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818508pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818508pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818508pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818508pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818508pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818508pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818508pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818508pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818508pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818508pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818508pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818508pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818508pubmed:statusMEDLINElld:pubmed
pubmed-article:11818508pubmed:monthFeblld:pubmed
pubmed-article:11818508pubmed:issn0888-8809lld:pubmed
pubmed-article:11818508pubmed:authorpubmed-author:OlefskyJerrol...lld:pubmed
pubmed-article:11818508pubmed:authorpubmed-author:WorrallDoroth...lld:pubmed
pubmed-article:11818508pubmed:issnTypePrintlld:pubmed
pubmed-article:11818508pubmed:volume16lld:pubmed
pubmed-article:11818508pubmed:ownerNLMlld:pubmed
pubmed-article:11818508pubmed:authorsCompleteYlld:pubmed
pubmed-article:11818508pubmed:pagination378-89lld:pubmed
pubmed-article:11818508pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:meshHeadingpubmed-meshheading:11818508...lld:pubmed
pubmed-article:11818508pubmed:year2002lld:pubmed
pubmed-article:11818508pubmed:articleTitleThe effects of intracellular calcium depletion on insulin signaling in 3T3-L1 adipocytes.lld:pubmed
pubmed-article:11818508pubmed:affiliationDepartment of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego, La Jolla, California 92093, USA. dsears@ucsd.edulld:pubmed
pubmed-article:11818508pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11818508pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11818508pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11818508lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11818508lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11818508lld:pubmed